Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
Author(s) -
Xiaochuan Huo,
Youxiang Li,
Yuhua Jiang,
Xiaoyun Sun,
Lixue Gu,
Wenshi Guo,
Dapeng Sun
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000373990
Subject(s) - choroidal neovascularization , macular degeneration , vascular endothelial growth factor , neovascularization , angiogenesis , placental growth factor , inflammation , macrophage , retinopathy of prematurity , medicine , cancer research , immunology , vascular endothelial growth factor a , biology , vegf receptors , ophthalmology , in vitro , biochemistry , pregnancy , genetics , gestational age
Age-related macular degeneration (AMD) appears to be a disease with increasing incidence in Western countries and may develop into acquired blindness. Choroidal neovascularization (CNV) is the most frequent cause for AMD, and is commonly induced by regional inflammation. Past studies have highlighted vascular endothelial growth factor A (VEGF-A) as a major trigger for CNV. However, studies on the associated angiogenic factors other than VEGF-A are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom